IKNA
Price
$1.25
Change
-$0.00 (-0.00%)
Updated
Apr 2 closing price
Capitalization
60.32M
35 days until earnings call
VNDA
Price
$4.35
Change
-$0.16 (-3.55%)
Updated
Apr 3, 12:44 PM (EDT)
Capitalization
263.01M
27 days until earnings call
Ad is loading...

IKNA vs VNDA

Header iconIKNA vs VNDA Comparison
Open Charts IKNA vs VNDABanner chart's image
Ikena Oncology
Price$1.25
Change-$0.00 (-0.00%)
Volume$91.36K
Capitalization60.32M
Vanda Pharmaceuticals
Price$4.35
Change-$0.16 (-3.55%)
Volume$267
Capitalization263.01M
IKNA vs VNDA Comparison Chart
Loading...
IKNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VNDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IKNA vs. VNDA commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IKNA is a Hold and VNDA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (IKNA: $1.25 vs. VNDA: $4.51)
Brand notoriety: IKNA and VNDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IKNA: 76% vs. VNDA: 110%
Market capitalization -- IKNA: $60.32M vs. VNDA: $263.01M
IKNA [@Biotechnology] is valued at $60.32M. VNDA’s [@Biotechnology] market capitalization is $263.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IKNA’s FA Score shows that 1 FA rating(s) are green whileVNDA’s FA Score has 1 green FA rating(s).

  • IKNA’s FA Score: 1 green, 4 red.
  • VNDA’s FA Score: 1 green, 4 red.
According to our system of comparison, both IKNA and VNDA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IKNA’s TA Score shows that 4 TA indicator(s) are bullish while VNDA’s TA Score has 5 bullish TA indicator(s).

  • IKNA’s TA Score: 4 bullish, 4 bearish.
  • VNDA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both IKNA and VNDA are a good buy in the short-term.

Price Growth

IKNA (@Biotechnology) experienced а -3.85% price change this week, while VNDA (@Biotechnology) price change was -5.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.56%. For the same industry, the average monthly price growth was -9.64%, and the average quarterly price growth was -14.03%.

Reported Earning Dates

IKNA is expected to report earnings on May 08, 2025.

VNDA is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Biotechnology (-7.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VNDA($263M) has a higher market cap than IKNA($60.3M). VNDA YTD gains are higher at: -5.846 vs. IKNA (-23.780). VNDA has higher annual earnings (EBITDA): -32.53M vs. IKNA (-54.06M). VNDA has more cash in the bank: 375M vs. IKNA (124M). IKNA has less debt than VNDA: IKNA (7.52M) vs VNDA (12.4M). VNDA has higher revenues than IKNA: VNDA (199M) vs IKNA (0).
IKNAVNDAIKNA / VNDA
Capitalization60.3M263M23%
EBITDA-54.06M-32.53M166%
Gain YTD-23.780-5.846407%
P/E RatioN/A126.00-
Revenue0199M-
Total Cash124M375M33%
Total Debt7.52M12.4M61%
FUNDAMENTALS RATINGS
VNDA: Fundamental Ratings
VNDA
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
57
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IKNAVNDA
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
65%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
71%
Momentum
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
82%
MACD
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
67%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
73%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
76%
Advances
ODDS (%)
Bullish Trend 11 days ago
82%
Bullish Trend 18 days ago
70%
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
69%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
82%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
69%
View a ticker or compare two or three
Ad is loading...
IKNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VNDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MUEUX34.450.24
+0.70%
MFS Blended Research Core Equity R4
AOTAX28.40N/A
N/A
Virtus Emerging Markets Opps A
JLVIX67.45N/A
N/A
JHancock Fundamental Large Cap Core I
BUISX13.55N/A
N/A
Buffalo Small Cap Growth Institutional
BPGSX12.27N/A
N/A
Boston Partners Global Sustainablty Ins

IKNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IKNA has been closely correlated with ABCZF. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if IKNA jumps, then ABCZF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IKNA
1D Price
Change %
IKNA100%
N/A
ABCZF - IKNA
72%
Closely correlated
N/A
ATRA - IKNA
72%
Closely correlated
+2.00%
AMLX - IKNA
54%
Loosely correlated
+13.17%
VNDA - IKNA
37%
Loosely correlated
+0.22%
FATE - IKNA
35%
Loosely correlated
+1.70%
More